NASDAQ: FTH

Faeth Therapeutics, Inc.

$24.39
-0.09 (-0.37%)as of 2026-08-07
1-year price · 252 sessions
Key stats
52-week range$24.39
$7.21$36.16
Today
Open
24.60
Day high
25.32
Day low
24.06
Prev close
24.48
Volume
202K
Valuation
Mkt cap
$630M
P/E (TTM)
EPS (TTM)
P/B
3.6
P/S
-129.9
Dividend
Yield
Per share
Insider & institutional activity · SEC Form 4 / 13F
  • Insiders net buying $1.2M over the last 3 months (22 open-market buys, 0 sales)
  • Cluster buying — multiple insiders bought within days
See all FTH insider trades →

Faeth Therapeutics, Inc. (FTH) is a Healthcare company listed on NASDAQ. The stock is up 220% over the past year. Over the trailing 3 months, insiders filed 22 open-market buys and 0 sales (SEC Form 4).

Faeth Therapeutics, Inc. (FTH) financials & analyst ratings

Fundamentals (TTM)

Margins
Gross margin2740.8%
Operating margin4098.5%
Net margin4030.7%
FCF margin919.4%
Growth & returns
Revenue growth
Revenue growth (fwd)
EPS growth
Return on equity-113.0%
Return on assets-103.3%

Analyst consensus · 6 analysts

BuyBuy 5Hold 1Sell 0Avg target $57 (+131.7%)Range $51–$60

Source: exchange market data + company filings. Figures are trailing-twelve-month or as most recently reported. For informational purposes only — not investment advice.

Track FTH with Drillr

SEC filings, earnings calls, insider activity, alt-data signals — all queryable through Drillr's AI terminal and MCP API.

Try Drillr for free